IFPMA in Brief

IFPMA in Brief

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

Our Resources

Join IFPMA

There are many challenges in improving public health policy for current and future generations. To play an effective role in advancing these policies, the research-based biopharmaceutical industry needs an informed and credible voice in the conversation with the global health community. That voice is IFPMA.

LEARN MORE

Our Blog

Latest Tweets

Come and join us @IHEID & @CHGlobalHealth & @IFPMA on Tuesday 23 January to hear more about the future of health in… https://t.co/Ujad3e0V7z
7 8
  @IFPMA
RT @AMRAlliance: In our survey, 90% of companies view current R&D incentives as “insufficient” or “far to go”. Here’s @IFPMA DG @ThomasCuen…
2
  @IFPMA
11 out of 11 large R&D pharma members responded to the @AMRAlliance survey on what actions they are taking to… https://t.co/6sooNGx51P
  @IFPMA
RT @ipwatch: Now on IPW: Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives https://t.co/IBlIuaEPXd
3
  @IFPMA
22 @AMRAlliance members invested USD 2bn in 2016 in AMR-relevant products. Sustainable pull incentives to research… https://t.co/TtmSTzQRvM
1
  @IFPMA